Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fentanyl Buccal Tablets for Pain Anxiety in Chronic Pain
NCT00387010Phase 3Terminated
- Sponsor
- Cephalon, Inc.
- Start
- Dec 2006
- Primary completion
- Oct 2007
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of fentanyl in breakthrough pain, sponsored by Cephalon, Inc.. Started Dec 2006; status: terminated.
02
Drugs
fentanyl
03
Conditions
breakthrough pain
Beyond the preview
Go deeper on NCT00387010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00387010.